Literature DB >> 7448527

Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling.

K M Laurence, N James, M Miller, H Campbell.   

Abstract

One hundred and seventy-four women who had previously had a child with a neural-tube defect were assessed retrospectively on the quality of their diets during the first trimester of that pregnancy, between pregnancies, and during the first trimester of other pregnancies. They were then studied prospectively during the first trimester of 186 following pregnancies and the outcome of these was recorded. One hundred and three women (with 109 pregnancies) were given dietary counselling before the pregnancy, the remaining 71 (with 77 pregnancies) not being counselled. Seventy-eight (72%) of the counselled women improved their diet compared with only nine (12%) of the uncounselled women. The difference was significant (p < 0.001). There were three recurrences of neural-tube defects in the counselled women (3%) and five recurrences in the uncounselled (7%). Although this difference was not significant, the relative risk in the counselled group was reduced to less than half of that in the uncounselled group. All eight recurrences occurred in the 45 pregnancies in women taking poor diets (18%), whereas there were no recurrences in the 141 other pregnancies. This difference is significant (p < 0.001). It is concluded that women receiving adequate diets have a lower incidence and recurrence of fetal neural-tube defects than women receiving poor diets and that dietary counselling may be effective in reducing the incidence of fetal neural-tube defects.

Entities:  

Mesh:

Year:  1980        PMID: 7448527      PMCID: PMC1715083          DOI: 10.1136/bmj.281.6255.1592

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route.

Authors:  J B THIERSCH
Journal:  Am J Obstet Gynecol       Date:  1952-06       Impact factor: 8.661

2.  Maternal smoking and congenital malformations: an epidemiological study.

Authors:  J L Kelsey; T Dwyer; T R Holford; M B Bracken
Journal:  J Epidemiol Community Health (1978)       Date:  1978-06

3.  Spina bifida and anencephalus in greater London.

Authors:  C O Carter; K Evans
Journal:  J Med Genet       Date:  1973-09       Impact factor: 6.318

4.  Clues to the aetiology of neural tube malformations.

Authors:  C O Carter
Journal:  Dev Med Child Neurol       Date:  1974-12       Impact factor: 5.449

5.  On neural-tube defects: an epidemiological elicitation of etiological factors.

Authors:  N W Choi; F A Klaponski
Journal:  Neurology       Date:  1970-04       Impact factor: 9.910

6.  Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects.

Authors:  K M Laurence; C O Carter; P A David
Journal:  Br J Prev Soc Med       Date:  1968-10

7.  A family study of major central nervous system malformations in South Wales.

Authors:  C O Carter; P A David; K M Laurence
Journal:  J Med Genet       Date:  1968-06       Impact factor: 6.318

8.  Hormonal pregnancy tests and congenital malformation.

Authors:  I Gal; B Kirman; J Stern
Journal:  Nature       Date:  1967-10-07       Impact factor: 49.962

9.  Vitamin deficiencies and neural tube defects.

Authors:  R W Smithells; S Sheppard; C J Schorah
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

10.  Possible prevention of neural-tube defects by periconceptional vitamin supplementation.

Authors:  R W Smithells; S Sheppard; C J Schorah; M J Seller; N C Nevin; R Harris; A P Read; D W Fielding
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

View more
  19 in total

1.  Effects of oral contraceptive usage on b(12) and folate levels.

Authors:  J A Mountifield
Journal:  Can Fam Physician       Date:  1985-08       Impact factor: 3.275

Review 2.  Genetic modifiers and oligogenic inheritance.

Authors:  Maria Kousi; Nicholas Katsanis
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

3.  Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study.

Authors:  Patrizia De Marco; Elisa Merello; Maria Grazia Calevo; Samantha Mascelli; Daniela Pastorino; Lucia Crocetti; Pierangela De Biasio; Gianluca Piatelli; Armando Cama; Valeria Capra
Journal:  Childs Nerv Syst       Date:  2011-01-05       Impact factor: 1.475

Review 4.  Multivitamins for the prevention of neural tube defects. How convincing is the evidence?

Authors:  R W Smithells
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 5.  Paediatrics--Part I.

Authors:  B L Priestley; C J Harrison; M P Gerrard; A Gibson
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

6.  Claimants for mobility allowance: causes of disability and the scope for prevention.

Authors:  G M Robertson
Journal:  J R Coll Gen Pract       Date:  1982-07

Review 7.  Can vitamins prevent neural tube defects?

Authors:  J M Elwood
Journal:  Can Med Assoc J       Date:  1983-11-15       Impact factor: 8.262

8.  Five years' experience of a "prepregnancy" clinic for insulin-dependent diabetics.

Authors:  J M Steel; F D Johnstone; A F Smith; L J Duncan
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

9.  Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.

Authors:  Bridget S Mosley; Mario A Cleves; Anna Maria Siega-Riz; Gary M Shaw; Mark A Canfield; D Kim Waller; Martha M Werler; Charlotte A Hobbs
Journal:  Am J Epidemiol       Date:  2008-10-25       Impact factor: 4.897

10.  Apparent prevention of neural tube defects by periconceptional vitamin supplementation.

Authors:  R W Smithells; S Sheppard; C J Schorah; M J Seller; N C Nevin; R Harris; A P Read; D W Fielding
Journal:  Arch Dis Child       Date:  1981-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.